Overview
Diamorphine (heroin) is a narcotic analgesic that may be habit-forming. It is a controlled substance (opium derivative) listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 (1987). Sale is forbidden in the United States by Federal statute. (Merck Index, 11th ed) Internationally, diamorphine is controlled under Schedules I and IV of the Single Convention on Narcotic Drugs. As heroin, it is illegal to manufacture, possess, or sell in the United States and the UK. However, under the name diamorphine, heroin is a legal prescription drug in the United Kingdom.
Indication
Diamorphine, as a prescription medication in the United Kingdom, is indicated for use in the treatment of severe pain associated with surgical procedures, myocardial infarction or pain in the terminally ill and for the relief of dyspnoea in acute pulmonary edema .
Associated Conditions
No associated conditions information available.
Clinical Trials
| Title | Posted | Study ID | Phase | Status | Sponsor | 
|---|---|---|---|---|---|
| 2019/06/05 | N/A | Completed | |||
| 2014/08/06 | Not Applicable | Completed | York Teaching Hospitals NHS Foundation Trust | ||
| 2010/08/04 | Phase 1 | Completed | University Hospital, Basel, Switzerland | ||
| 2010/01/14 | Not Applicable | Completed | |||
| 2009/04/13 | Phase 4 | Terminated | |||
| 2008/07/04 | Phase 3 | Completed | |||
| 2005/12/22 | Phase 3 | Completed | |||
| 2005/09/15 | Phase 3 | Completed | |||
| 1999/09/21 | Phase 2 | Withdrawn | |||
| 1999/09/21 | Phase 2 | Withdrawn | 
FDA Drug Approvals
| Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date | 
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
| Approved Product | Authorization Holder | Status | Issued Date | 
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
| Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date | 
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
| Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date | 
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
| Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date | 
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
| Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date | 
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
| Approved Product | Company | DIN | Dosage Form | Strength | Market Date | 
|---|---|---|---|---|---|
| DIACETYLMORPHINE HYDROCHLORIDE | 02525003 | Powder For Solution - Intramuscular
            
            , 
          
            
              
              Intravenous | 5000 MG / VIAL | 4/11/2022 | |
| DIAMORPHINE HYDROCHLORIDE INJ 30MG/ML BP | technilab pharma inc. | 00781479 | Powder For Solution - Intramuscular
            
            , 
          
            
              
              Intravenous
            
            , 
          
            
              
              Subcutaneous | 30 MG / ML | 12/31/1988 | 
| DIACETYLMORPHINE HYDROCHLORIDE | 02524996 | Powder For Solution - Intramuscular
            
            , 
          
            
              
              Intravenous | 200 MG / VIAL | 6/16/2022 | |
| DIAMORPHINE HYDROCHLORIDE INJ 100MG/ML BP | technilab pharma inc. | 00781460 | Powder For Solution - Intramuscular
            
            , 
          
            
              
              Intravenous
            
            , 
          
            
              
              Subcutaneous | 100 MG / ML | 12/31/1988 | 
CIMA AEMPS Drug Approvals
| Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status | 
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
| Approved Product | Company | License Number | Dosage Form | Strength | Approval Date | 
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
| Approved Product | Company | License Number | Dosage Form | Strength | Approval Date | 
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
| Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date | 
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
| Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date | 
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.
